Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

AirSculpt Technologies Reaffirms FY22 Guidance

2022 Outlook The Company is reiterating its revenue outlook of $175-179 million and its Adjusted EBITDA guidance in the range of $58 – $60 million. The Company has opened two
byBill Haddad
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

2022 Outlook

The Company is reiterating its revenue outlook of $175-179 million and its Adjusted EBITDA guidance in the range of $58 – $60 million. The Company has opened two centers in 2022 and anticipates opening two additional centers in the second half of the year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Scilex Holding Co Announces That Its Majority Stockholder, Sorrento Therapeutics, Inc., Has Issued A Notice That Sorrento’s Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Stock Distributed By Sorrento To Its Stockholders As A Divid…

By Happy Mohamed
April 26, 8:02 AM
Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))) announced that its majority stockholder, Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", Sorrento", )))) has issued a notice that Sorrento's

SCLX